StonvexLoading…
StonvexStonvexStonvexCore line items from LGIH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.71B | $2.20B | $2.36B | $2.30B |
Operating Income | $79.78M | $212.15M | $233.25M | $390.11M |
Net Income | $72.55M | $196.07M | $199.23M | $326.57M |
EPS (Diluted) | $3.12 | $8.30 | $8.42 | $13.76 |
Total Assets | $3.93B | $3.76B | $3.41B | $3.12B |
Total Liabilities | $1.83B | $1.72B | $1.55B | $1.48B |
Cash & Equivalents | $61.25M | $53.20M | $48.98M | $32.00M |
Free Cash Flow OCF − CapEx | $-140.90M | $-145.69M | $-58.41M | $-371.64M |
Shares Outstanding | 23.13M | 23.40M | 23.58M | 23.31M |